Lowered expression of three of the nine genes—ASB2, NUDT10, and SRPX—was significantly correlated with poor prognosis in PCa patients (Fig. 4b), while two more genes—ETNK2 and NTN1—were trending (p < 0.10, Additional file 12: Figure S8). This evidence concerns the gene SRPX and posterior cortical atrophy.